Compass Therapeutics Statistics
Total Valuation
CMPX has a market cap or net worth of $627.10 million. The enterprise value is $518.90 million.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, before market open.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CMPX has 171.57 million shares outstanding. The number of shares has increased by 4.28% in one year.
| Current Share Class | 171.57M |
| Shares Outstanding | 171.57M |
| Shares Change (YoY) | +4.28% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 5.48% |
| Owned by Institutions (%) | 47.20% |
| Float | 125.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.30 |
| P/TBV Ratio | 6.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.66, with a Debt / Equity ratio of 0.11.
| Current Ratio | 7.66 |
| Quick Ratio | 7.28 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -51.84% and return on invested capital (ROIC) is -33.88%.
| Return on Equity (ROE) | -51.84% |
| Return on Assets (ROA) | -31.14% |
| Return on Invested Capital (ROIC) | -33.88% |
| Return on Capital Employed (ROCE) | -65.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.77M |
| Employee Count | 35 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +138.00% in the last 52 weeks. The beta is 1.31, so CMPX's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | +138.00% |
| 50-Day Moving Average | 3.08 |
| 200-Day Moving Average | 2.43 |
| Relative Strength Index (RSI) | 67.09 |
| Average Volume (20 Days) | 998,311 |
Short Selling Information
The latest short interest is 10.25 million, so 5.98% of the outstanding shares have been sold short.
| Short Interest | 10.25M |
| Short Previous Month | 9.53M |
| Short % of Shares Out | 5.98% |
| Short % of Float | 8.20% |
| Short Ratio (days to cover) | 7.60 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -67.84M |
| Pretax Income | -47.24M |
| Net Income | -62.03M |
| EBITDA | -67.32M |
| EBIT | -67.84M |
| Earnings Per Share (EPS) | -$0.45 |
Full Income StatementBalance Sheet
The company has $100.95 million in cash and $9.90 million in debt, giving a net cash position of $91.05 million or $0.53 per share.
| Cash & Cash Equivalents | 100.95M |
| Total Debt | 9.90M |
| Net Cash | 91.05M |
| Net Cash Per Share | $0.53 |
| Equity (Book Value) | 93.21M |
| Book Value Per Share | 0.67 |
| Working Capital | 92.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$45.25 million and capital expenditures -$62,000, giving a free cash flow of -$45.32 million.
| Operating Cash Flow | -45.25M |
| Capital Expenditures | -62,000 |
| Free Cash Flow | -45.32M |
| FCF Per Share | -$0.26 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CMPX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.28% |
| Shareholder Yield | -4.28% |
| Earnings Yield | -10.17% |
| FCF Yield | -7.43% |
Analyst Forecast
The average price target for CMPX is $13.50, which is 269.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.50 |
| Price Target Difference | 269.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 235.87% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CMPX has an Altman Z-Score of 0.89 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.89 |
| Piotroski F-Score | 1 |
